- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Siemens finds very high field MR partner
MR manufacturers agree that clinical sites considering the purchase of a high-performance scanner are now seriously examining 3T systems alongside 1.5T scanners--and choosing 3T, if their budgets permit. With that realization, Siemens Medical Solutions
MR manufacturers agree that clinical sites considering the purchase of a high-performance scanner are now seriously examining 3T systems alongside 1.5T scanners--and choosing 3T, if their budgets permit. With that realization, Siemens Medical Solutions has cut an agreement to collaborate with the Biomedical Imaging Technology Center (BITC) at Emory University to develop new clinical MR applications. Using its new Magnetom Trio 3T scanner, Siemens and BITC are preparing to launch projects aimed at advancing the physics and chemistry of 3T MR, as well as enhancing the hardware and software of 3T technology. The whole-body scanner will be focused on certain advanced clinical applications, including cardiovascular pathologies, musculoskeletal diseases, venous tumors, and anatomic and functional aspects of the brain.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
